Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$102.98
+0.4%		$106.35
$81.97
▼
$137.49
$178.19B0.5911.51 million shs4.93 million shs
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$43.71
+0.9%		$46.90
$42.20
▼
$105.65
$63.35B0.5718.81 million shs24.83 million shs
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$64.81
+1.1%		$68.30
$58.75
▼
$89.77
$29.27B0.74.31 million shs3.48 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$401.65
+2.1%		$372.69
$328.57
▼
$603.88
$141.89B1.472.46 million shs2.97 million shs
10 Best Stocks to Own - Fall 2026 Cover
10 Best Stocks to Own - Fall 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%+0.27%-12.23%+16.60%-24.86%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.00%+0.96%-13.85%-2.01%-55.63%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.00%+0.31%-14.29%+5.76%-14.39%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.00%+6.55%+3.83%-2.39%-10.35%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$102.98
+0.4%		$106.35
$81.97
▼
$137.49
$178.19B0.5911.51 million shs4.93 million shs
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$43.71
+0.9%		$46.90
$42.20
▼
$105.65
$63.35B0.5718.81 million shs24.83 million shs
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$64.81
+1.1%		$68.30
$58.75
▼
$89.77
$29.27B0.74.31 million shs3.48 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$401.65
+2.1%		$372.69
$328.57
▼
$603.88
$141.89B1.472.46 million shs2.97 million shs
10 Best Stocks to Own - Fall 2026 Cover
10 Best Stocks to Own - Fall 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%+0.27%-12.23%+16.60%-24.86%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.00%+0.96%-13.85%-2.01%-55.63%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.00%+0.31%-14.29%+5.76%-14.39%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.00%+6.55%+3.83%-2.39%-10.35%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.96
Moderate Buy$119.5016.04% Upside
Boston Scientific Corporation stock logo
BSX
Boston Scientific
2.68
Moderate Buy$70.2760.76% Upside
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
2.48
Hold$77.7319.93% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.68
Moderate Buy$508.6826.65% Upside

Current Analyst Ratings Breakdown

Latest ABT, BSX, ISRG, and GEHC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/21/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Oppenheimer Holdings, Inc. logo
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$85.00 ➝ $65.00
9/18/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
9/17/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
9/17/2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$79.00
9/17/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Neutral$57.00 ➝ $50.00
9/9/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$60.00 ➝ $56.00
9/8/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$135.00
9/8/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$469.00
8/25/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$56.00
8/25/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$115.00 ➝ $135.00
8/21/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
(Data available from 9/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$46.59B3.83$7.01 per share14.68$30.35 per share3.39
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$20.07B3.16$4.07 per share10.74$16.49 per share2.65
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$21.27B1.38$5.94 per share10.91$22.80 per share2.84
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$11.03B12.86$9.47 per share42.40$50.52 per share7.95
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$3.0933.3316.941.9011.65%17.69%9.44%10/21/2026 (Estimated)
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$2.90B$2.4717.7012.821.0117.50%19.28%10.89%10/28/2026 (Estimated)
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$2.08B$4.3614.8611.981.699.33%20.12%5.74%11/4/2026 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.86B$8.7346.0140.082.9728.45%16.91%14.83%10/20/2026 (Estimated)

Latest ABT, BSX, ISRG, and GEHC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/29/2026Q2 2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.83$0.86+$0.03$0.61$5.38 billion$5.44 billion
7/29/2026Q2 2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$1.04$1.13+$0.09$1.24$5.26 billion$5.30 billion
7/16/2026Q2 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.28$1.31+$0.03$0.53$12.52 billion$12.59 billion
7/16/2026Q2 2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.48$2.80+$0.32$2.29$2.83 billion$2.89 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.45%+10.39%81.55%54 Years
Boston Scientific Corporation stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$0.140.22%N/A3.21%1 Years
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A

Latest ABT, BSX, ISRG, and GEHC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/17/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.632.47%10/15/202610/15/202611/16/2026
6/30/2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
quarterly$0.03500.23%7/24/20267/24/20268/14/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.57
1.38
0.97
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.43
1.24
0.74
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.92
1.26
0.97
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.96
3.91

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
89.07%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
82.06%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.34%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.36%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.72 billionOptionable
Boston Scientific Corporation stock logo
BSX
Boston Scientific
59,0001.45 billion1.44 billionOptionable
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
54,000451.69 million450.06 millionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
17,021353.28 million351.16 millionOptionable

Recent News About These Companies

Q2 earnings roundup: Intuitive Surgical (NASDAQ:ISRG) and the rest of the surgical equipment & consumables - specialty segment
 |  msn.comhttps://www.msn.com/en-us/money/other/q2-earnings-roundup-intuitive-surgical-nasdaq-isrg-and-the-rest-of-the-surgical-equipment-consumables-specialty-segment/ar-AA2cFOwR
How Far Could ISRG Stock Bounce From Here?
 |  trefis.comT
Ambulatory Surgery Centers Are Becoming ISRG's New Growth Engine
 |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/ambulatory-surgery-centers-becoming-isrgs-160700348.html
Ambulatory Surgery Centers Are Becoming ISRG's New Growth Engine
September 21 at 1:11 PM  |  zacks.comhttps://www.zacks.com/stock/news/2993132/ambulatory-surgery-centers-are-becoming-isrg-s-new-growth-engine?cid=cs-stocknewsapi-ft-analyst_blog|quick_take-2993132
Intuitive Surgical stock heads into the open after a 2.6% gain
September 21 at 8:48 AM  |  ad-hoc-news.deA
Intuitive Surgical (NASDAQ:ISRG) Downgraded by Wall Street Zen to Hold
September 20 at 1:07 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31033531
Intuitive Surgical (NASDAQ:ISRG) Downgraded to "Hold" Rating by Wall Street Zen
September 20 at 1:05 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-intuitive-surgical-nasdaq-isrg-downgraded-to-hold-rating-by-wall-street-zen-2026-09-20/
121,867 Shares in Intuitive Surgical, Inc. $ISRG Acquired by Nykredit A S
September 19 at 3:30 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-121867-shares-in-intuitive-surgical-inc-isrg-acquired-by-nykredit-a-s-2026-09-19/
Intuitive Surgical, Inc. (NASDAQ:ISRG) Given Average Rating of "Moderate Buy" by Brokerages
September 19 at 2:13 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-intuitive-surgical-inc-nasdaq-isrg-given-average-rating-of-moderate-buy-by-brokerages-2026-09-19/
Can Intuitive Surgical Make Up For A Lower Price Per Surgery?
September 18 at 1:17 PM  |  trefis.comT
Fredrik Widman Sells 1,089 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock
September 18 at 6:12 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31031426
Is ISRG Stock Really As Expensive As It Looks?
September 17, 2026  |  trefis.comT
3 Cash-Heavy Stocks to Research Further
September 17, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/3-cash-heavy-stocks-research-073604512.html
Intuitive Surgical (NASDAQ:ISRG) VP Sells $407,765.16 in Stock
September 17, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-isrg-insider-buying-and-selling-2026-09-17/
Intuitive Surgical Stock (ISRG) Opinions on Recent Price Decline Ahead of Q3 Earnings
September 16, 2026  |  quiverquant.comQ
ISRG Wins EU Nod to Expand da Vinci SP in Gynecologic Procedures
September 16, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/isrg-wins-eu-nod-expand-153700902.html
Intuitive Surgical (NASDAQ:ISRG) VP Fredrik Widman Sells 1,089 Shares
September 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-intuitive-surgical-nasdaq-isrg-vp-fredrik-widman-sells-1089-shares-2026-09-16/
ISRG Wins EU Nod to Expand da Vinci SP in Gynecologic Procedures
September 16, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2990741/isrg-wins-eu-nod-to-expand-da-vinci-sp-in-gynecologic-procedures?cid=cs-stocknewsapi-ft-analyst_blog|company_news_medical_sector-2990741
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
September 16, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2990441/intuitive-surgical-inc-isrg-is-attracting-investor-attention-here-is-what-you-should-know?cid=cs-stocknewsapi-ft-fundamental_analysis|most_searched_stocks_v1-2990441
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
September 16, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/intuitive-surgical-inc-isrg-attracting-130002776.html
3 Healthcare Stocks with More Than 20% Upside and Recent Buy Ratings
September 16, 2026  |  tipranks.comhttps://www.tipranks.com/news/3-healthcare-stocks-with-more-than-20-upside-and-recent-buy-ratings?utm_source=marketbeat.com&utm_medium=referral

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Data center hallway with rows of server racks and cables, plus a monitoring room with computer screens in the background.
AI Token Costs Are Changing the Hardware vs. Software Debate
By Jeffrey Neal Johnson | September 6, 2026
NVIDIA logo over a computer chip, server racks, and an upward-trending green stock price chart.
NVIDIA’s Blockbuster Quarter May Still Undersell How Big the AI Buildout Is
By Thomas Hughes | August 27, 2026
Illustration of a computer chip on a circuit board with an upward green stock chart line in a server room.
Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
By Thomas Hughes | August 31, 2026
A Tesla concept vehicle with illuminated front light bar drives on a road against a city skyline at dusk.
Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
By Sam Quirke | September 8, 2026
A freight train with orange locomotives pulls intermodal shipping containers through a rail yard at sunset.
This Corner of the Market Is Outperforming the Benchmark—And It's Not AI
By Ryan Hasson | September 10, 2026
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$102.98 +0.37 (+0.36%)
As of 03:58 PM Eastern

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Boston Scientific stock logo

Boston Scientific NYSE:BSX

$43.71 +0.37 (+0.85%)
As of 03:58 PM Eastern

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

GE HealthCare Technologies stock logo

GE HealthCare Technologies NASDAQ:GEHC

$64.81 +0.68 (+1.06%)
As of 04:00 PM Eastern

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$401.65 +8.32 (+2.12%)
As of 04:00 PM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas